BioReliance appoints Dr James Kramer VP of global biologics operations
This article was originally published in Scrip
Executive Summary
BioReliance, a contract services company that provides biologics safety testing, toxicology, viral manufacturing and laboratory animal diagnostic services to the pharmaceutical and biopharmaceutical industries worldwide, has appointed Dr James Kramer to the newly created position of vice-president of global biologics operations. He joined the company in December 2007 as vice-president of operations, US biologics.